McArdle C S, McMillan D C, Hole D J
University Department of Surgery, Royal Infirmary, Glasgow, UK.
Br J Surg. 2006 Apr;93(4):483-8. doi: 10.1002/bjs.5269.
Previous studies have drawn attention to the high postoperative mortality and poor survival of patients who present as an emergency with colon cancer. However, these patients are a heterogeneous group. The aim of the present study was to establish, having adjusted for case mix, the size of the differences in postoperative mortality and 5-year survival between patients presenting as an emergency with evidence of blood loss, obstruction and perforation.
The study included 2068 patients who presented with colon cancer between 1991 and 1994 in Scotland. Five-year survival rates and the adjusted hazard ratios were calculated.
Thirty-day postoperative mortality following potentially curative resection was consistently higher in patients who presented with evidence of blood loss, obstruction or perforation (all P < 0.005) than in elective patients. Following potentially curative surgery, cancer-specific survival at 5 years was 74.6 per cent compared with 60.9, 51.6 and 46.5 per cent in those who presented with blood loss, obstruction and perforation respectively (all P < 0.001). The corresponding adjusted hazard ratios (95 per cent confidence interval) for cancer-specific survival, relative to elective patients, were 1.62 (1.22 to 2.15), 2.22 (1.78 to 2.75) and 2.93 (1.82 to 4.70) for patients presenting with evidence of blood loss, obstruction or perforation (all P < 0.001).
Compared with patients who undergo elective surgery for colon cancer, those who present as an emergency with evidence of blood loss, obstruction or perforation have higher postoperative mortality rates and poorer cancer-specific survival.
先前的研究已关注到以急诊形式就诊的结肠癌患者术后死亡率高且生存率低的情况。然而,这些患者是一个异质性群体。本研究的目的是在对病例组合进行调整后,确定伴有失血、梗阻和穿孔证据的急诊患者与择期患者在术后死亡率和5年生存率方面的差异大小。
该研究纳入了1991年至1994年期间在苏格兰出现结肠癌症状的2068例患者。计算了5年生存率和调整后的风险比。
伴有失血、梗阻或穿孔证据的患者在进行潜在根治性切除术后30天的死亡率始终高于择期手术患者(所有P<0.005)。在进行潜在根治性手术后,5年癌症特异性生存率为74.6%,而伴有失血、梗阻和穿孔的患者分别为60.9%、51.6%和46.5%(所有P<0.001)。相对于择期手术患者,伴有失血、梗阻或穿孔证据的患者癌症特异性生存的相应调整后风险比(95%置信区间)分别为1.62(1.22至2.15)、2.22(1.78至2.75)和2.93(1.82至4.70)(所有P<0.001)。
与接受结肠癌择期手术的患者相比,伴有失血、梗阻或穿孔证据的急诊患者术后死亡率更高,癌症特异性生存率更低。